Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis of refractory secondary hyperparathyroidism.

Mariano Rodriguez1, Antonio Canalejo, Bartolome Garfia

  • 1Nephrology Services and Research Unit, Hospital Universitario Reina Sofia, Córdoba, Spain. mrodriguez@hrs.sas.junta-andalucia.es

Kidney International. Supplement
|May 2, 2002
PubMed
Summary

Poor response to calcitriol in uremic patients with severe hyperparathyroidism is linked to high phosphate levels. Intrinsic cellular changes in parathyroid glands contribute to treatment resistance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sub-Antarctic subtidal and intertidal macroalgae in rocky ecosystems of Inútil Bay, Tierra del Fuego in Southern Patagonia.

Biodiversity data journal·2026
Same author

Corrigendum to "Ceftriaxone administration reduces vascular calcification associated with experimental models of chronic kidney disease." [Biomed. Pharmacother. 197 (2026), 119131].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Ceftriaxone administration reduces vascular calcification associated with experimental models of chronic kidney disease.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Probiotic Supplementation in Chronic Kidney Disease: Outcomes on Uremic Toxins, Inflammation, and Vascular Calcification from Experimental and Clinical Models.

Toxins·2026
Same author

The Phosphate/Urea Nitrogen Ratio in Urine-A Method to Assess the Relative Intake of Inorganic Phosphate.

Nutrients·2025
Same author

New biomarkers of inflammation associated with haemodialysis.

Clinical kidney journal·2025

Area of Science:

  • Nephrology
  • Endocrinology
  • Cell Biology

Background:

  • Calcitriol therapy aims to lower parathyroid hormone (PTH) in uremic patients.
  • A subset of patients exhibit resistance to calcitriol treatment.
  • Severe hyperparathyroidism and uncontrolled serum phosphate are predictors of poor calcitriol response.

Purpose of the Study:

  • To investigate the mechanisms underlying calcitriol resistance in uremic hyperparathyroidism.
  • To identify factors contributing to abnormal parathyroid gland function in uremia.

Main Methods:

  • Analysis of factors stimulating PTH secretion and synthesis (hypocalcemia, hyperphosphatemia, low calcitriol).
  • In vitro studies using parathyroid tissue from uremic patients undergoing parathyroidectomy.
  • Examination of calcium and calcitriol response in nodular hyperplasia.

Related Experiment Videos

Main Results:

  • Nodular hyperplasia in uremic parathyroid glands shows abnormal responses to calcium and calcitriol.
  • Decreased calcium-sensing receptors and vitamin D receptors in hyperplastic cells suggest intrinsic regulatory defects.
  • High serum phosphate is a key factor in secondary hyperparathyroidism pathogenesis and calcitriol resistance.

Conclusions:

  • Calcitriol resistance in severe uremic hyperparathyroidism is associated with uncontrolled phosphate levels.
  • Intrinsic cellular changes, including altered receptor expression, contribute to parathyroid dysfunction in uremia.
  • Phosphate accumulation drives PTH secretion and parathyroid cell proliferation, exacerbating secondary hyperparathyroidism.